An inflammatory checkpoint regulates recruitment of graft-versus-host reactive T cells to peripheral tissues

Journal of Experimental Medicine

Volumn 203, Issue 8, 2006, Pages 2021-2031

  Chakraverty, Ronjon ^a   Côté, Daniel ^a   Buchli, Jennifer ^a   Cotter, Pete ^a   Hsu, Richard ^a   Zhao, Guiling ^a   Sachs, Teviah ^a   Pitsillides, Costas M ^a   Bronson, Roderick ^b   Means, Terry ^a   Lin, Charles ^a   Sykes, Megan ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHIMERA; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HEMATOPOIETIC CELL; INFLAMMATION; INFLAMMATORY CELL; IRRADIATION; LEUKOCYTE; LYMPHOID TISSUE; MICROSCOPY; MOUSE; NONHUMAN; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; T LYMPHOCYTE; UPREGULATION;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CROSS-PRIMING; GRAFT VS HOST DISEASE; GRAFT VS HOST REACTION; INFLAMMATION; MICE; RADIATION CHIMERA; SKIN; T-LYMPHOCYTES; TOLL-LIKE RECEPTORS;

EID: 33746932816     PISSN: 00221007     EISSN: 00221007     Source Type: Journal    
DOI: 10.1084/jem.20060376     Document Type: Article

References (59)

1. Wysocki, C.A., A. Panoskaltsis-Mortari, B.R. Blazar, and J.S. Serody. 2005. Leukocyte migration and graft-versus-host disease. Blood. 105:4191-4199.
2. Sprent, J., M. Schaefer, D. Lo, and R. Korngold. 1986. Functions of purified L3T4+ and Lyt-2+ cells in vitro and in vivo. Immunol. Rev. 91:195-218.
3. Shlomchik, W.D., M.S. Couzens, C.B. Tang, J. McNiff, M.E. Robert, J. Liu, M.J. Shlomchik, and S.G. Emerson. 1999. Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science. 285:412-415.
4. Teshima, T., R. Ordemann, P. Reddy, S. Gagin, C. Liu, K.R. Cooke, and J.L. Ferrara. 2002. Acute graft-versus-host disease does not require alloantigen expression on host epithelium. Nat. Med. 8:575-581.
5. Beilhack, A., S. Schulz, J. Baker, G.F. Beilhack, C.B. Wieland, E.I. Herman, E.M. Baker, Y.A. Cao, C.H. Contag, and R.S. Negrin. 2005. In vivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T cell subsets. Blood. 106:1113-1122.
6. Panoskaltsis-Mortari, A., A. Price, J.R. Hermanson, E. Taras, C. Lees, J.S. Serody, and B.R. Blazar. 2004. In vivo imaging of graft-versus-host-disease in mice. Blood. 103:3590-3598.
7. Masopust, D., V. Vezys, A.L. Marzo, and L. Lefrancois. 2001. Preferential localization of effector memory cells in nonlymphoid tissue. Science. 291:2413-2417.
8. Reinhardt, R.L., A. Khoruts, R. Merica, T. Zell, and M.K. Jenkins. 2001. Visualizing the generation of memory CD4 T cells in the whole body. Nature. 410:101-105.
9. Schwartz, R.H. 2003. T cell anergy. Annu. Rev. Immunol. 21:305-334.
10. Liu, Z., and L. Lefrancois. 2004. Intestinal epithelial antigen induces mucosal CD8 T cell tolerance, activation, and inflammatory response. J. Immunol. 173:4324-4330.
11. Vezys, V., S. Olson, and L. Lefrancois. 2000. Expression of intestine-specific antigen reveals novel pathways of CD8 T cell tolerance induction. Immunity. 12:505-514.
12. Tomita, Y., A. Khan, and M. Sykes. 1994. Role of intrathymic clonal deletion and peripheral anergy in transplantation tolerance induced by bone marrow transplantation in mice conditioned with a nonmyeloablative regimen. J. Immunol. 153:1087-1098.
13. Manilay, J.O., D.A. Pearson, J.J. Sergio, K.G. Swenson, and M. Sykes. 1998. Intrathymic deletion of alloreactive T cells in mixed bone marrow chimeras prepared with a nonmyeloablative conditioning regimen. Transplantation. 66:96-102.
14. Sykes, M., M.A. Sheard, and D.H. Sachs. 1988. Effects of T cell depletion in radiation bone marrow chimeras. II. Requirement for allogeneic T cells in the reconstituting bone marrow inoculum for subsequent resistance to breaking of tolerance. J. Exp. Med. 168:661-673.
15. Mapara, M.Y., Y.M. Kim, J. Marx, and M. Sykes. 2003. Donor lymphocyte infusion-mediated graft-versus-leukemia effects in mixed chimeras established with a nonmyeloablative conditioning regimen: extinction of graft-versus- leukemia effects after conversion to full donor chimerism. Transplantation. 76:297-305.
16. Mapara, M.Y., Y.M. Kim, S.P. Wang, R. Bronson, D.H. Sachs, and M. Sykes. 2002. Donor lymphocyte infusions mediate superior graft-versus-leukemia effects in mixed compared to fully allogeneic chimeras: a critical role for host antigen-presenting cells. Blood. 100:1903-1909.
17. Kolb, H.J., C. Schmid, A.J. Barrett, and D.J. Schendel. 2004. Graft-versus-leukemia reactions in allogeneic chimeras. Blood. 103:767-776.
18. Xun, C.Q., J.S. Thompson, C.D. Jennings, S.A. Brown, and M.B. Widmer. 1994. Effect of total body irradiation, busulfan-cyclophosphamide, or cyclophosphamide conditioning on inflammatory cytokine release and development of acute and chronic graft-versus-host disease in H-2-incompatible transplanted SCID mice. Blood. 83:2360-2367.
19. Hill, G.R., J.M. Crawford, K.R. Cooke, Y.S. Brinson, L. Pan, and J.L. Ferrara. 1997. Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines. Blood. 90:3204-3213.
20. Sorror, M.L., M.B. Maris, B. Storer, B.M. Sandmaier, R. Diaconescu, C. Flowers, D.G. Maloney, and R. Storb. 2004. Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities. Blood. 104:961-968.
21. Sha, W.C., C.A. Nelson, R.D. Newberry, D.M. Kranz, J.H. Russell, and D.Y. Loh. 1988. Positive and negative selection of an antigen receptor on T cells in transgenic mice. Nature. 336:73-76.
22. Dey, B., Y.G. Yang, F. Preffer, A. Shimizu, K. Swenson, D. Dombkowski, and M. Sykes. 1999. The fate of donor T-cell receptor transgenic T cells with known host antigen specificity in a graft-versus-host disease model. Transplantation. 68:141-149.
23. Gonzalez, M., S.A. Quezada, B.R. Blazar, A. Panoskaltsis-Mortari, A.Y. Rudensky, and R.J. Noelle. 2002. The balance between donor T cell anergy and suppression versus lethal graft-versus-host disease is determined by host conditioning. J. Immunol. 169:5581-5589.
24. Murali-Krishna, K., and R. Ahmed. 2000. Cutting edge: naive T cells masquerading as memory cells. J. Immunol. 165:1733-1737.
25. Maury, S., B. Salomon, D. Klatzmann, and J.L. Cohen. 2001. Division rate and phenotypic differences discriminate alloreactive and nonalloreactive T cells transferred in lethally irradiated mice. Blood. 98:3156-3158.
26. Johansson-Lindbom, B., M. Svensson, M.A. Wurbel, B. Malissen, G. Marquez, and W. Agace. 2003. Selective generation of gut tropic T cells in gut-associated lymphoid tissue (GALT): requirement for GALT dendritic cells and adjuvant. J. Exp. Med. 198:963-969.
27. Mora, J.R., M.R. Bono, N. Manjunath, W. Weninger, L.L. Cavanagh, M. Rosemblatt, and U.H. Von Andrian. 2003. Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells. Nature. 424:88-93.
28. Mora, J.R., G. Cheng, D. Picarella, M. Briskin, N. Buchanan, and U.H. von Andrian. 2005. Reciprocal and dynamic control of CD8 T cell homing by dendritic cells from skin- and gut-associated lymphoid tissues. J. Exp. Med. 201:303-316.
29. Klonowski, K.D., and L. Lefrancois. 2005. The CD8 memory T cell subsystem: integration of homeostatic signaling during migration. Semin. Immunol. 17:219-229.
30. Teshima, T., G.R. Hill, L. Pan, Y.S. Brinson, M.R. van den Brink, K.R. Cooke, and J.L. Ferrara. 1999. IL-11 separates graft-versus-leukemia effects from graft-versus-host disease after bone marrow transplantation. J. Clin. Invest. 104:317-325.
31. Ferrara, J.L., K.R. Cooke, and T. Teshima. 2003. The pathophysiology of acute graft-versus-host disease. Int. J. Hematol. 78:181-187.
32. Eyrich, M., G. Burger, K. Marquardt, W. Budach, K. Schilbach, D. Niethammer, and P.G. Schlegel. 2005. Sequential expression of adhesion and costimulatory molecules in graft-versus-host disease target organs after murine bone marrow transplantation across minor histocompatibility antigen barriers. Biol. Blood Marrow Transplant. 11:371-382.
33. Hemmi, H., T. Kaisho, O. Takeuchi, S. Sato, H. Sanjo, K. Hoshino, T. Horiuchi, H. Tomizawa, K. Takeda, and S. Akira. 2002. Small antiviral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat. Immunol. 3:196-200.
34. Caramalho, I., T. Lopes-Carvalho, D. Ostler, S. Zelenay, M. Haury, and J. Demengeot. 2003. Regulatory T cells selectively express Toll-like receptors and are activated by lipopolysaccharide. J. Exp. Med. 197:403-411.
35. Pasare, C., and R. Medzhitov. 2003. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science. 299:1033-1036.
36. Palamara, F., S. Meindl, M. Holcmann, P. Luhrs, G. Stingl, and M. Sibilia. 2004. Identification and characterization of pDC-like cells in normal mouse skin and melanomas treated with imiquimod. J. Immunol. 173:3051-3061.
37. Klonowski, K.D., K.J. Williams, A.L. Marzo, D.A. Blair, E.G. Lingenheld, and L. Lefrancois. 2004. Dynamics of blood-borne CD8 memory T cell migration in vivo. Immunity. 20:551-562.
38. Masopust, D., V. Vezys, E.J. Usherwood, L.S. Cauley, S. Olson, A.L. Marzo, R.L. Ward, D.L. Woodland, and L. Lefrancois. 2004. Activated primary and memory CD8 T cells migrate to nonlymphoid tissues regardless of site of activation or tissue of origin. J. Immunol. 172:4875-4882.
39. Chakraverty, R., H. Eom, J. Sachs, J. Buchli, P. Cotter, R. Hsu, G. Zhao, and M. Sykes. 2006. Host MHC Class II+ antigen-presenting cells and CD4 cells are required for CD8-dependent graft-versus-leukemia responses following delayed donor leukocyte infusions. Blood. In press.
40. Briscoe, D.M., R.S. Cotran, and J.S. Pober. 1992. Effects of tumor necrosis factor, lipopolysaccharide, and IL-4 on the expression of vascular cell adhesion molecule-1 in vivo. Correlation with CD3+ T cell infiltration. J. Immunol. 149:2954-2960.
41. Chalasani, G., Q. Li, B.T. Konieczny, L. Smith-Diggs, B. Wrobel, Z. Dai, D.L. Perkins, F.K. Baddoura, and F.G. Lakkis. 2004. The allograft defines the type of rejection (acute versus chronic) in the face of an established effector immune response. J. Immunol. 172:7813-7820.
42. Issekutz, T.B., and J.M. Stoltz. 1989. Stimulation of lymphocyte migration by endotoxin, tumor necrosis factor, and interferon. Cell. Immunol. 120:165-173.
43. Goldrath, A.W., L.Y. Bogatzki, and M.J. Bevan. 2000. Naive T cells transiently acquire a memory-like phenotype during homeostasis-driven proliferation. J. Exp. Med. 192:557-564.
44. Wu, Z., S.J. Bensinger, J. Zhang, C. Chen, X. Yuan, X. Huang, J.F. Markmann, A. Kassaee, B.R. Rosengard, W.W. Hancock, et al. 2004. Homeostatic proliferation is a barrier to transplantation tolerance. Nat. Med. 10:87-92.
45. Hess, A.D., and C.J. Thoburn. 1997. Immunobiology and immunotherapeutic implications of syngeneic/autologous graft-versus-host disease. Immunol. Rev. 157:111-123.
46. Darabi, K., A.Y. Karulin, B.O. Boehm, H.H. Hofstetter, Z. Fabry, J.C. LaManna, J.C. Chavez, M. Tary-Lehmann, and P.V. Lehmann. 2004. The third signal in T cell-mediated autoimmune disease? J. Immunol. 173:92-99.
47. Lang, K.S., M. Recher, T. Junt, A.A. Navarini, N.L. Harris, S. Freigang, B. Odermatt, C. Conrad, L.M. Ittner, S. Bauer, et al. 2005. Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease. Nat. Med. 11:138-145.
48. Vezys, V., and L. Lefrancois. 2002. Cutting edge: inflammatory signals drive organ-specific autoimmunity to normally cross-tolerizing endogenous antigen. J. Immunol. 169:6677-6680.
49. Waldner, H., M. Collins, and V.K. Kuchroo. 2004. Activation of antigen-presenting cells by microbial products breaks self tolerance and induces autoimmune disease. J. Clin. Invest. 113:990-997.
50. Gunzer, M., H. Riemann, Y. Basoglu, A. Hillmer, C. Weishaupt, S. Balkow, B. Benninghoff, B. Ernst, M. Steinert, T. Scholzen, et al. 2005. Systemic administration of a TLR7 ligand leads to transient immune incompetence due to peripheral blood leukocyte depletion. Blood. 106:2424-2432.
51. Caron, G., D. Duluc, I. Fremaux, P. Jeannin, C. David, H. Gascan, and Y. Delneste. 2005. Direct stimulation of human T cells via TLR5 and TLR7/8: flagellin and R-848 up-regulate proliferation and IFN-gamma production by memory CD4+ T cells. J. Immunol. 175:1551-1557.
52. Luster, A.D., R. Alon, and U.H. von Andrian. 2005. Immune cell migration in inflammation: present and future therapeutic targets. Nat. Immunol. 6:1182-1190.
53. Hallahan, D.E., S. Virudachalam, and J. Kuchibhotla. 1998. Nuclear factor kappaB dominant negative genetic constructs inhibit X-ray induction of cell adhesion molecules in the vascular endothelium. Cancer Res. 58:5484-5488.
54. Sugerman, P.B., S.B. Faber, L.M. Willis, A. Petrovic, G.F. Murphy, J. Pappo, D. Silberstein, and M.R. van den Brink. 2004. Kinetics of gene expression in murine cutaneous graft-versus-host disease. Am. J. Pathol. 164:2189-2202.
55. Mapara, M.Y., C. Leng, Y.M. Kim, R. Bronson, A.D. Luster, and M. Sykes. 2006. Expression of chemokines in GVHD target organs is influenced by the type of conditioning and genetic factors. Biol. Blood Marrow Transplant. 12:623-634.
56. Pelot, M.R., D.A. Pearson, K. Swenson, G. Zhao, J. Sachs, Y.G. Yang, and M. Sykes. 1999. Lymphohematopoietic graft-vs.-host reactions can be induced without graft-vs.-host disease in murine mixed chimeras established with a cyclophosphamide-based nonmyeloablative conditioning regimen. Biol. Blood Marrow Transplant. 5:133-143.
57. Sykes, M., V.S. Abraham, M.W. Harty, and D.A. Pearson. 1993. IL-2 reduces graft-versus-host disease and preserves a graft-versus-leukemia effect by selectively inhibiting CD4+ T cell activity. J. Immunol. 150:197-205.
58. Abdi, R., T.K. Means, and A.D. Luster. 2003. Chemokines in islet allograft rejection. Diabetes Metab. Res. Rev. 19:186-190.
59. Novak, J., I. Georgakoudi, X. Wei, A. Prossin, and C.P. Lin. 2004. In vivo flow cytometer for real-time detection and quantification of circulating cells. Opt. Lett. 29:77-79.